Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
29,575,441
-
Share change
-
-3,947,613
-
Total reported value
-
$334,025,598
-
Put/Call ratio
-
806%
-
Price per share
-
$11.29
-
Number of holders
-
101
-
Value change
-
-$42,243,566
-
Number of buys
-
46
-
Number of sells
-
46
Institutional Holders of HOMOLOGY MEDICINES INC - COM (FIXX) as of Q4 2020
As of 31 Dec 2020,
HOMOLOGY MEDICINES INC - COM (FIXX) was held by
101 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,575,441 shares.
The largest 10 holders included
5AM Venture Management, LLC, JPMORGAN CHASE & CO, Temasek Holdings (Private) Ltd, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, Bellevue Group AG, VANGUARD GROUP INC, CITADEL ADVISORS LLC, and FMR LLC.
This page lists
101
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.